Trial
NCT01256905
Attention Modulation for Treatment of Parkinson's Disease and Dementia With Lewy Bodies
UnknownWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
NYU Langone Health
Collaborators
Cephalon
Condition
Parkinsons Disease
Intervention
Armodafinil
Why stopped
PI departure from institution
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-08-23